Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock, +26

New England Journal of Medicine

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock, +26

Blood

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, +31

The Lancet Haematology

Positron Emission TomographyInterim Pet ScanPrognostic BiomarkersLymphoid NeoplasiaOncologic Imaging +9

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial

Dominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, +30

The Lancet Oncology

Hematological MalignancyInterim AnalysisOncologyMarrow TransplantationTransplantation +8

Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway.

Krystyna Dąbrowska, Adam Opolski, Joanna Wietrzyk, +14

PubMed

Antitumor ActivityImmunologyBacteriophageImmunotherapyCancer Biology +17

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients

Aleksandra Butrym, Justyna Rybka, Dagmara Baczyńska, +3

Journal of Experimental & Clinical Cancer Research

Alterations of biomechanics in cancer and normal cells induced by doxorubicin

Kaja Frączkowska, Marcin Bacia, Magdalena Przybyło, +9

Biomedicine & Pharmacotherapy

MechanobiologyMedicineCell-matrix InteractionCytoskeletonCell Biomechanics +9

The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy

Justyna Rybka, Aleksandra Butrym, Tomasz Wróbel, +5

Leukemia Research

Hematological MalignancyToll-like ReceptorsMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia +8

Expression of MicroRNA-331 Can Be Used as a Predictor for Response to Therapy and Survival in Acute Myeloid Leukemia Patients

Aleksandra Butrym, Justyna Rybka, Dagmara Baczyńska, +3

Biomarkers in Medicine

Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study

Elżbieta Kalicińska, Monika Biernat, Justyna Rybka, +11

Journal of Clinical Medicine

Vascular DiseasePrognosisEndothelial ActivationCovid-19 EpidemiologyEasix Score +25